Coordinatore | TEKNOLOGISK INSTITUT
Organization address
address: GREGERSENSVEJ 1 contact info |
Nazionalità Coordinatore | Denmark [DK] |
Totale costo | 3˙890˙118 € |
EC contributo | 2˙990˙698 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2011-two-stage |
Funding Scheme | CP-FP |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-01-01 - 2015-12-31 |
# | ||||
---|---|---|---|---|
1 |
TEKNOLOGISK INSTITUT
Organization address
address: GREGERSENSVEJ 1 contact info |
DK (TAASTRUP) | coordinator | 823˙780.00 |
2 |
BACTIGUARD AB
Organization address
address: BIBLIOTEKSGATAN 25 contact info |
SE (STOCKHOLM) | participant | 539˙200.00 |
3 |
BIOMODICS APS
Organization address
address: STENGARDS ALLE 31A contact info |
DK (KGS LYNGBY) | participant | 475˙740.00 |
4 |
LABORATOIRE D'EVALUTION DES MATERIELS IMPLANTABLES SA
Organization address
city: MARTILLAC contact info |
FR (MARTILLAC) | participant | 367˙564.00 |
5 |
ST GEORGE'S HOSPITAL MEDICAL SCHOOL
Organization address
address: Cranmer Terrace contact info |
UK (LONDON) | participant | 338˙881.00 |
6 |
WEIZMANN INSTITUTE OF SCIENCE
Organization address
address: HERZL STREET 234 contact info |
IL (REHOVOT) | participant | 316˙550.00 |
7 |
NOVOZYMES A/S
Organization address
address: Krogshoejvej 36 contact info |
DK (BAGSVAERD) | participant | 128˙983.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Outbreaks of clinical infections affect many thousands of patients in Europe yearly. The present effective treatment for infections is large doses of systemically applied drugs. There is a high risk of recurring infections and biofilm formation for patients dependent on long term in-dwelling catheters and the extended dependency on antibiotics result in clinical drug resistance. We present a new tool for minimizing drug resistance by upgrading existing and future medical devices through a unique self-regenerating surface that prevents biofilm formation by a two-fold stealth attack mechanism. This will be achieved by an interpenetrating polymer network (IPN) that allows for long term release of a range of antimicrobial strategies, such as antimicrobial peptides (AMPs) . The IPNs contain hydrogels where the AMP is stored until the release starts at the insertion of the device with an expected long-term effect. The first line of defence will be a fixed galvanic noble metal alloy coating that will prevent bacteria from colonizing the surface. Local and site-specific treatment with long term effect instead of systemic treatment implies improved patient management and citizen well-fare.'
European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis
Read MoreMultidisciplinary Approaches to Translational Research In Conduct Syndromes
Read MorePlatform for sharing best practices for management of rare diseases
Read More